The Food and Drug Administration (FDA) has approved Restylane Refyne and Restylane Defyne dermal fillers from Galderma for the treatment of nasolabial folds.
The US Food and Drug Administration (FDA) has approved Allergan to market JUVÉDERM VOLBELLA XC for lip augmentation and to correct perioral rhytides in adults over the age of 21.
Aesthetic distributor Fusion GT has introduced the Carbomix device that combines carboxytherapy and hyperbaric oxygen therapy.
Global pharmaceutical company Allergan has received approval from the US Food and Drug Administration (FDA) to market the Natrelle Inspira Cohesive breast implants
The Lightfusion LED platform has been approved by the US Food and Drug Administration (FDA) as a Class 2 medical device for the treatment of periorbital wrinkles.
Global aesthetic manufacturer Teoxane Laboratories has announced that the US Food and Drug Administration (FDA) has approved three of its dermal fillers.
Results of a new study indicate that Botox (onabotulinumtoxinA, Allergan) can be used to treat crow’s feet lines safely and effectively.
Global pharmaceutical company Allergan has launched Juvéderm VOLUX, a hyaluronic acid injectable gel that uses the existing VYCROSS patented technology.
Global pharmaceutical company Allergan has announced plans to build a USD $14.7 million centre to promote medical aesthetics innovations in Chengdu, China, which will train 3,000 practitioners per year.
A multi-platform technology aimed at providing long-lasting skin tightening has been launched in the UK.